Oct 30, 2025 | News, Biologics News
The blockbuster-drug model is fading fast. In its place? Highly personalized treatments—cell and gene therapies, mRNA vaccines, and rare-disease biologics, produced in small, patient-specific batches. That shift is rewriting the rules of biomanufacturing. Smaller... 
Sep 23, 2025 | Biologics News, News
For years, biotech innovation has been anchored to coastal powerhouses like Boston and San Francisco. But as the industry enters its next growth cycle, regional hubs are emerging as strong contenders, and in some cases, they may hold the advantage. Cost Advantages... 
Jun 3, 2025 | HR & Management, Biologics News, News
Biotech startups thrive on big ideas—but turning those ideas into breakthroughs takes the right people. And finding those people? That’s often easier said than done. Scientific talent is not only rare—it’s tough to identify, tougher to vet, and often the toughest to... 
Mar 6, 2025 | Biologics News, News
As biotech and pharmaceutical companies become more digitized, cybersecurity is emerging as a critical yet often overlooked issue in the industry. From safeguarding proprietary drug formulations to protecting patient data in clinical trials, cyber threats pose... 
Feb 27, 2025 | Business Tips, Biologics News
While much attention in the biotech and pharmaceutical industries is focused on innovation, regulatory challenges, and AI-driven advancements, one critical issue remains underdiscussed: the impact of supply chain disruptions. From raw material shortages to complex...